Nagano T, Hirano T, Hirobe M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Free Radic Res Commun. 1991;12-13 Pt 1:221-7. doi: 10.3109/10715769109145790.
Novel iron and copper complexes having tris[N-(5-methyl-2-pyridylmethyl)-2-aminoethyl]amine (5MeT-PAA), tris[N-(3-methyl-2-pyridylmethyl)-2-aminoethyl]amine (3MeTPAA), tris[N-(5-methoxycarbonyl-2-pyridylmethyl)-2-aminoethyl]amine (TNAA), tris[(2-thienylmethyl)-2-aminoethyl]amine (TTAA), tris[(2-furylmethyl)-2-aminoethyl]amine (TFAA) or tris[(2-imidazoyl)-2-aminoethyl]amine (TIAA) as ligand, were synthesized to examine the superoxide dismutase (SOD) activity. The concentrations of Fe-3MeTPAA and Fe-TIAA equivalent to 1 unit of SOD (IC50) were 0.5 microM and 1.0 microM, respectively. Fe-3MeTPAA and Fe-TIAA had higher SOD activity than other Fe and Cu complexes and protected Escherichia coli cells from paraquat toxicity. In case of using tris[N-(6-methyl-2-pyridylmethyl)-2-aminoethyl]amine (6MeTPAA) as ligand, the Fe complex could not be obtained, which may be due to the steric hindrance of 6-methyl substituent. Generally, Cu complexes had low SOD activity, compared with Fe complexes, and could not suppress paraquat toxicity.
合成了以三[N-(5-甲基-2-吡啶甲基)-2-氨基乙基]胺(5MeT-PAA)、三[N-(3-甲基-2-吡啶甲基)-2-氨基乙基]胺(3MeTPAA)、三[N-(5-甲氧基羰基-2-吡啶甲基)-2-氨基乙基]胺(TNAA)、三[(2-噻吩基甲基)-2-氨基乙基]胺(TTAA)、三[(2-呋喃基甲基)-2-氨基乙基]胺(TFAA)或三[(2-咪唑基)-2-氨基乙基]胺(TIAA)为配体的新型铁和铜配合物,以检测超氧化物歧化酶(SOD)活性。相当于1个SOD单位(IC50)的Fe-3MeTPAA和Fe-TIAA的浓度分别为0.5 microM和1.0 microM。Fe-3MeTPAA和Fe-TIAA的SOD活性高于其他铁和铜配合物,并能保护大肠杆菌细胞免受百草枯毒性。在用三[N-(6-甲基-2-吡啶甲基)-2-氨基乙基]胺(6MeTPAA)作为配体的情况下,无法得到铁配合物,这可能是由于6-甲基取代基的空间位阻所致。一般来说,与铁配合物相比,铜配合物的SOD活性较低,并且不能抑制百草枯毒性。